PSTO 18: IMPAACT 2019 - Phase I/II Study of the Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less than 12 Years of Age (Per Patient Reimbursement)

Project: Research project

Project Details

StatusFinished
Effective start/end date10/1/19 → 6/29/24

Funding

  • Johns Hopkins University (200445436)
  • ViiV Healthcare (200445436)